IDEX IEX · NYSE
$239.46 +0.39% (+$0.92)
Summary
65 / 100 · Bulios Score
What speaks for it
- It has raised its dividend 16 years in a row and pays out only 40% of profit.
- Out of every 100 USD of revenue, 15 USD is left as net profit.
What to watch
- The share price is above the Bulios Fair Price.
- Earnings per share fell by 6.0% a year over the last 3 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 32.9 USD for 1 USD of yearly profit. Over the last five years it was 31.3 USD on average.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 8.0% a year over 5 years. Over the last 3 years it grew by 2.8% a year. For the next fiscal year analysts expect revenue to grow by 6.8%. Earnings per share fell by 6.0% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 55 USD
- Sales and administration 24 USD
- Taxes and other 6.3 USD
- Net profit 15 USD
Net profit, industry median (Industrial - Machinery) 7.0 USD
Out of every 100 USD of revenue, 15 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesRepaying all its debt would take 2.6 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 1.21%
- Paid out of profit
- 40%
- Raised in a row
- 16 years
You receive $2.90 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 15
- Hold 14
- Sell 0
Today's price within the analysts' price targets
The average target of $260.75 is 8.9% above today's price. 52% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Health And Science Technologies 43%
- Fluid And Metering Technologies 35%
- Fire And Safety Diversified Products 22%
By region
- UNITED STATES 53%
- Europe 26%
- Asia 17%
- North America, Excluding United States 3.9%
Health And Science Technologies brings in 43% of revenue.
Segments in detail